Catch up on the top radiology content of the past week.

Reportedly the only point-of-care ultrasound system that can estimate liver stiffness and attenuation that correlate to MRI-PDFF, Velacur One also may facilitate higher reimbursement than non-imaging elastography.

In the second part of a recent interview, Chris Mattern. M.D., discussed the increasing burden of non-clinical tasks upon radiologist workloads and the potential of the emerging enterprise imaging platform MosaicOS to address efficiency and restore the focus on clinical care.

Incorporating technology from Siemens Healthineers’ Magnetom Skyra Fit system, the Invision 3T Recharge Operating Suite offers AI-powrred protocols and automated image reconstruction capabilities.

Could the NeedleVue LC1 Ultrasound System reinvent real-time ultrasound-assisted needle guidance for interventional procedures?

In the second of a two-part podcast episode, Jeremie Calais, M.D., and Robert Flavell, M.D., discuss current and emerging alpha-emitting therapies, possible roles for artificial intelligence (AI), and what the future may hold for theranostic applications in patients with prostate cancer.

Emphasizing advanced orchestration of imaging workflows, the Rhapsody Image Director software reportedly facilitates streamlined efficiency and infrastructure that accommodates multimodal AI tools.

Patient with biochemical recurrence of prostate cancer who had PSMA PET/CT prior to salvage radiotherapy had better survival rates at one, two and five years, according to newly published research.

Researchers noted a 78 percent malignancy rate when associated architectural distortion was present on digital breast tomosynthesis (DBT) with highly suspicious masses or microcalcifications.

The iPETcertum software reportedly provides automated segmentation and enhanced visualization of regions of interest on PET scans with a single click.

In a recent interview, Tammie Benzinger, M.D., Ph.D., discussed the utility of portable low-field MRI to help identify patients in remote settings who may be viable candidates for subsequent MRI workup and consideration for new anti-amyloid therapies in treating Alzheimer’s disease.

Amid a variety of alternative approaches to addressing the radiologist shortage, one should be mindful of the educational track it takes to become a radiologist.

Catch up on the top radiology content of the past week.

In comparison to computed tomography and bone scintigraphy, FDG PET/CT detected more oligometastatic and polymetastatic disease in patients with locally advanced breast cancer, according to a new study.

A deep learning multimodal model that incorporates MRI features offered nearly double the sensitivity for predicting post-prostatectomy biochemical recurrence of prostate cancer in comparison to the traditional CAPRA-S scoring system.

In the first of a two-part podcast episode, Jeremie Calais, M.D., and Robert Flavell, M.D., discuss recent advances with PSMA-targeted radiotracers in the treatment of metastatic castration-resistant prostate cancer (mCRPC), and the role of imaging criteria in monitoring patients treated with PSMA-targeted radionuclide therapy.

In addition to facilitating centralized scanning for a variety of imaging, the TechLive system may help ease the strain of technologist shortages and broaden access to advanced imaging exams.

In light of the ongoing challenges with navigating malpractice risk and administrative burdens in radiology, these authors issue a call for increased communication and collaboration with ordering clinicians.

In a recent interview, Chris Mattern, M.D., discussed a confluence of trends that may be contributing to burnout in radiology, early retirements and a shifting preference from full-time to part-time roles in radiology.

Lower proportions of extremely dense breasts and high BRCAT lifetime risk among Black women in comparison to White women may have resulted in a lower likelihood of eligibility for supplemental screening insurance coverage in Pennsylvania, according to new research.